Low blood oxygen on Everest offers treatment hope

By Michael Kahn

LONDON (Reuters) - A team of British doctors conducting experiments in the “Death Zone” of Mount Everest has recorded the lowest levels of blood oxygen in humans, far below those of critically ill patients.

The findings published on Wednesday could one day lead to better care for patients with heart and lung ailments in intensive care units, premature babies and others suffering from similar low-oxygen levels, known as hypoxia.

“We want to understand why humans respond differently to low oxygen levels,” Mike Grocott, a researcher at University College London, who led the study, said in a telephone interview.

“The problem with studying critically ill patients is there are so many other things going on it makes it difficult to single out the effects of any one variable.”

The study took place in the so-called “Death Zone” on Everest — the area above 8,000 meters (26,250 feet) where thin air limits the amount of oxygen getting into the lungs and can lead to organ failure and coma even for the fittest individuals.

The team of eight doctors reached the 8,850-meter summit via the South Col route but carried out their experiment about 400 meters lower because of severe weather at the top.

After finding an area that provided some shelter, four of the team members removed their gloves, unzipped their down suits and had blood drawn from the femoral artery in the groin.

“The disadvantage is you have to uncover a little bit more of yourself than you would like at those temperatures,” Grocott said. The outside temperature at the time was about minus 25 C (-13 F).

An analysis showed what doctors had long suspected — that high-altitude climbers have incredibly low levels of oxygen in their blood, normally seen only in patients close to death.

The readings were also the lowest-ever recorded in humans, as low as 2.55 kilopascals. This compares to a normal level of 12-14 kilopascals for healthy people and a level of eight kilopascals for critically ill patients, Grocott added.

A kilopascal is a unit of pressure.

“We did an extensive search and couldn’t find any measurements in humans that were lower and not many that were even close,” he said.

Grocott and colleagues, who published their findings in the New England Journal of Medicine, believe a build-up of fluid in the lungs due to the high altitude might have contributed to the low oxygen levels.

While further research is needed, the results suggest that some critically ill patients may be able to tolerate lower oxygen levels before receiving oxygen or other interventions that run the risk of side effects, Grocott said.

“What is interesting about this is there may be some patients who can tolerate lower levels and get less harm from these other interventions,” Grocott said.

(Reporting by Michael Kahn; editing by Maggie Fox and Michael Roddy)


Related Posts:

NEW YORK (Reuters Health) - Although many doctors worry about breaking bad news about seriously ill patients to their kin, most family members want to know the truth, a study published Monday suggests. Research has shown that many doctors hesitate to be fully open with critically ill patients and their families — opting, for example, to

Full Post: Families want doctors to share bad news

LONDON (Reuters) - A dangerous, drug-resistant bacterium normally found in soil and water is on the increase in hospitals worldwide, an infectious disease expert warned on Tuesday. Acinetobacter baumannii is more resistant than the MRSA superbug and accounts for about 30 percent of drug-resistant hospital infections, said Matthew Falagas, director of the Alfa Institute of Biomedical

Full Post: Dangerous bacteria on increase: expert

By Michael Kahn LONDON (Reuters) - A novel drug combination using Genzyme Corp’s Mozobil shows it may be possible to spur bone marrow into releasing extra adult stem cells into the bloodstream to repair the heart and broken bones, researchers said on Thursday. The study of mice raises hope that researchers could use the same technique to

Full Post: New drug combo may boost stem cell production

By Michael Kahn LONDON (Reuters) - Five centuries after Leonardo da Vinci’s intricate drawings transformed understanding of the human heart, a new computer model promises to do the same for modern-day cardiac care, experts say. The model — so realistic its four chambers beat in the same asymmetrical rhythm on screen as does a real heart in

Full Post: New cyber heart model recalls da Vinci’s sketches

By Michael Kahn LONDON (Reuters) - A new blood test will allow doctors more accurately to pinpoint patients likely to develop the symptoms of tuberculosis, researchers said on Monday. Traditional testing for the disease involves injecting the subject with components of the TB bacterium; a resultant swelling of the skin can signal dormant tuberculosis. Such skin tests are

Full Post: New TB blood test more accurate than skin test

Site Navigation

Most Read



  • kinwrite.com@gmail.com